Page last updated: 2024-08-26

artenimol and Carcinoma, Ductal

artenimol has been researched along with Carcinoma, Ductal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Habibi, Z; Hassan, ZM; Noori, S; Rezaei, B; Taghikhani, M1

Other Studies

1 other study(ies) available for artenimol and Carcinoma, Ductal

ArticleYear
Dihydroartemisinin can inhibit calmodulin, calmodulin-dependent phosphodiesterase activity and stimulate cellular immune responses.
    International immunopharmacology, 2010, Volume: 10, Issue:2

    Topics: Animals; Antineoplastic Agents; Artemisinins; Calmodulin; Carcinoma, Ductal; Cyclic Nucleotide Phosphodiesterases, Type 1; Erythrocytes; Female; Hypersensitivity, Delayed; Immunity, Cellular; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C

2010